Variable | OS | DFS | ||
---|---|---|---|---|
Multivariable analysis | HR (95% CI) | P-value | HR (95% CI) | P-value |
Pre-therapy tumor size (cm) | ||||
≥ 5 vs. < 5 | 2.091 (1.176–3.715) | 0.012 | 1.821 (1.050–3.156) | 0.033 |
Clinical TNM stage | ||||
III/IVA vs. IIA/IIB | 1.488 (0.611–2.436) | 0.275 | 1.628 (0.925–2.864) | 0.091 |
NAC | ||||
Yes vs. no | 0.245 (0.103–0.811) | 0.039 | 0.591 (0.364–0.958) | 0.031 |
Histological grade | ||||
Poorly vs. well/moderate | - | - | 1.905 (1.125–3.328) | 0.046 |
Pathological T stage | ||||
T3/4a/4b vs. T0/1/2 | 2.266 (0.997–3.124) | 0.027 | 1.607 (0.974–2.652) | 0.063 |
Pathological N stage | ||||
N-positive vs. N-negative | 1.111 (0.677–1.821) | 0.677 | 1.109 (0.599–2.052) | 0.742 |
Lymphovascular invasion | ||||
Yes vs. no | 1.372 (0.917–1.821) | 0.531 | 1.984 (1.254–2.796) | 0.025 |
Pathological TNM stage | ||||
III/IV vs. 0/I/II | 1.992 (1.062–3.736) | 0.012 | 2.233 (1.198–4.162) | 0.011 |